ENFN - Enfusion, Inc.

QQQ $ 426.27 $ 6.25 (1.49 %)

DIA $ 385.03 $ 2.65 (0.69 %)

SPY $ 505.65 $ 5.93 (1.19 %)

TLT $ 89.02 $ 0.03 (0.03 %)

GLD $ 214.96 $ -0.53 (-0.25 %)

Previous Close

$ 9.35

Open

$ 9.30

Bid

$ 0.00 x 0

Ask

$ 9.36 x 100

Day's Range

$ 9.25 - $ 9.45

52 Week Range

$ 7.37 - $ 11.56

Volume

552,040

Average Volume

Market Cap

1.21B

Beta (5Y Monthly)

$ 1.43

PE Ratio (TTM)

$ 200.86

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-12-2024	12-31-2023	10-K
2	11-07-2023	09-30-2023	10-Q
3	08-08-2023	06-30-2023	10-Q
4	05-09-2023	03-31-2023	10-Q
5	03-10-2023	12-31-2022	10-K
6	11-10-2022	09-30-2022	10-Q
7	08-10-2022	06-30-2022	10-Q
8	05-13-2022	03-31-2022	10-Q
9	03-30-2022	12-31-2021	10-K
10	12-03-2021	09-30-2021	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Watching Enfusion; Spruce Point Capital Ma...
03/14/2024 13:32:05

https://www.sprucepointcap.com/research/enfusion-inc After conducting a forensic review of Enfusion, a technology provider for ...

12-information-technology-stocks-moving-in-thursdays-pre-market-session

12 Information Technology Stocks Moving In...
03/14/2024 13:06:04

A Glimpse Into The Expert Outlook On Enfus...
03/13/2024 14:04:11

B of A Securities Maintains Underperform o...
03/13/2024 12:10:37

B of A Securities analyst Koji Ikeda maintains Enfusion (NYSE:ENFN) with a Underperform and raises the price target from $8 ...

Enfusion Expects 2024 Revenue of $200M-$21...
03/12/2024 12:14:02

Financial outlook 13 These statements are forward-looking and actual results may differ materially. Refer to the “Forward-Looki...

Enfusion Q4 2023 Adj EPS $0.04 Misses $0.0...
03/12/2024 12:05:50

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.05 by 20 ...

Earnings Scheduled For March 12, 2024
03/12/2024 09:35:47

Companies Reporting Before The Bell • Aurora Mobile (NASDAQ:JG) is likely to report earnings for its fourth quarter.

Earnings Outlook For Enfusion
03/11/2024 15:02:35

enfusion-stock-to-remain-range-bound-in-2024-amid-stable-hedge-fund-market-goldman-sachs-analyst-downgrades-stock

Enfusion Stock To Remain Range-Bound In 20...
02/28/2024 20:11:29

Goldman Sachs downgrades Enfusion from Neutral to Sell, lowers price target from $9 to $8, expects stock to be range-bound in 2...

Goldman Sachs Downgrades Enfusion to Sell,...
02/28/2024 11:03:28

Goldman Sachs analyst Gabriela Borges downgrades Enfusion (NYSE:ENFN) from Neutral to Sell and lowers the price target from ...

JP Morgan Downgrades Enfusion: Here's What...
01/30/2024 17:00:32

JP Morgan Downgrades Enfusion to Underweig...
01/30/2024 10:47:04

JP Morgan analyst Alexei Gogolev downgrades Enfusion (NYSE:ENFN) from Neutral to Underweight and lowers the price target fro...

this-analyst-with-84-accuracy-rate-sees-around-13-upside-in-darden-restaurants---here-are-5-stock-picks-for-2023-from-wall-streets-most-accurate-analysts

This Analyst With 84% Accuracy Rate Sees A...
01/02/2024 14:35:34

U.S. stocks closed slightly lower on Friday, but the S&P 500 closed out last year with a gain of 24.2%. The Dow closed the ...

Piper Sandler Maintains Neutral on Enfusio...
12/20/2023 19:18:02

Piper Sandler analyst Sumeet Mody maintains Enfusion (NYSE:ENFN) with a Neutral and raises the price target from $9 to $10.

Enfusion Announces Appointment Of Neal Paw...
11/20/2023 13:16:40

UBS Initiates Coverage On Enfusion with Ne...
11/07/2023 13:52:25

UBS analyst Kevin Mcveigh initiates coverage on Enfusion (NYSE:ENFN) with a Neutral rating and announces Price Target of $9.

Enfusion Q3 EPS $0.02 Misses $0.05 Estimat...
11/07/2023 12:39:28

Enfusion (NYSE:ENFN) reported quarterly earnings of $0.02 per share which missed the analyst consensus estimate of $0.05 by 60 ...

Earnings Scheduled For November 7, 2023
11/07/2023 11:34:30

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings for its third quarter.

Goldman Sachs Maintains Neutral on Enfusio...
08/09/2023 15:45:59

Goldman Sachs analyst Gabriela Borges maintains Enfusion (NYSE:ENFN) with a Neutral and lowers the price target from $11.5 t...

Morgan Stanley Maintains Overweight on Enf...
08/09/2023 12:50:12

Morgan Stanley analyst James Faucette maintains Enfusion (NYSE:ENFN) with a Overweight and lowers the price target from $12 ...